[1]
“In Brief: Laboratory and clinical monitoring requirements for JAK inhibitors”, Can Dermatol Today, vol. 4, no. 1, pp. 20–22, Mar. 2023, Accessed: Mar. 19, 2026. [Online]. Available: https://canadiandermatologytoday.com/article/view/4-1-veillette